The global perfusion system market size is projected to reach USD 1.54 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is projected to advance at a CAGR of 4.7% from 2022 to 2030. Factors such as the growing prevalence of chronic diseases and the rise in the number of organ transplants and multiple organ failures are anticipated to boost the market growth. In addition, increasing investments in cell-based research and a rise in biologics manufacturing are further expected to impel the growth of the perfusion system industry.
There was a steep downfall in the sales of perfusion systems during the first half of the pandemic. The lockdowns and restrictions imposed by governments globally resulted in reduced patient visits to hospitals, a reduced number of surgeries, and a slowdown in R&D activities. However, with the increasing efforts of the government and healthcare professionals to curb the spread of the virus and prepare for similar events in the future, the market began to recover in 2021 and is expected to flourish during the forecast period.
Request a free sample copy or view report summary: Perfusion System Market Report
Based on application, the perfusion systems market is segmented into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo organ perfusion system. The cardiopulmonary perfusion system dominated the market in 2021 due to the high prevalence of cardiac diseases globally
In terms of region, North America accounted for the highest market share in 2021. The rising incidences of chronic disorders, a well-established healthcare sector, and a rise in the number of organ donors are driving the regional market growth
The COVID-19 pandemic had a significant negative impact on the market for perfusion systems. Factors such as the change in healthcare priorities, social distancing, and global lockdowns resulted in a reduced number of surgeries and a fall in the number of organ donations and transplants
The coronavirus outbreak led to a decline in the sales of perfusion systems; however, post the first wave of the pandemic, the market recovered and is expected to reach its pre-COVID growth level during the forecast period
Grand View Research has segmented the global perfusion system market based on application and region:
Perfusion System Application Outlook (Revenue, USD Million, 2017 - 2030)
Cardiopulmonary Perfusion System
Oxygenators
Heart-lung Machine
Perfusion Pumps
Cannula
Monitoring System
Others
Cell Perfusion System
Bioreactor Perfusion System
Microfluidic Perfusion System
Gravity/Pressure-driven Perfusion System
Small Mammal Organ Perfusion System
Ex-vivo Organ Perfusion System
Hypothermic
Normothermic
Perfusion System Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Asia Pacific
China
Japan
India
Australia
South Korea
Singapore
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
List of Key Players in the Perfusion System Market
Getinge AB, plc
LivaNova
Nipro Corporation
Terumo Corporation
XENIOS AG
Medtronic
Repligen Corporation
Spectrum Laboratories, Inc.
Harvard Bioscience, Inc.
ALA Scientific Instruments, Inc.
Lifeline Scientific, Inc.
Merck KGaA
XVIVO Perfusion AB.
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."